<p>(a) J8-specific serum IgG concentrations in donor BALB/c or recipient SCID mice. Serum samples were collected post-immunization (for donors) or post second administration of J8-DT or DT antiserum (for recipients). J8-specific IgG concentrations in serum of individual mice, are shown, with mean concentration represented as horizontal bars. (b) Protection induced in BALB/c and SCID mice by J8-DT following active (I/Ch) and/or passive immunization (PT/Ch). The mice were challenged with M1 GAS and their survival monitored. Mann-Whitney test was performed to compare the proportions of surviving mice. Significance is represented as * p<0.05 and ** p<0.01.</p
<p>Sera of 10 immunized mice per group were collected on days 15, 30, 45, 60, 75 and 90 after the fi...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
<p>Cohorts of BALB/c mice (n = 10/group) received a primary immunization on day 0 followed by three ...
<p>BALB/c mice were immunized with J8-DT/DT or PBS parenterally. For <i>in vivo</i> depletion of CD4...
<p>BALB/c mice were immunized with J8-DT/DT or PBS parenterally. For <i>in vivo</i> depletion of CD8...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
Vaccination with J8-DT, a leading GAS vaccine candidate, results in protective immunity in mice. Ana...
Vaccination with J8-DT, a leading GAS vaccine candidate, results in protective immunity in mice. Ana...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
<p>The development of J8-specific antibodies in mice (n = 5/group) that were sequentially infected w...
<p>Values shown represent the reciprocal of the endpoint ELISA titer for each mouse (closed circles)...
<p>Anti IgY in the sera of mice immunized with normal IgY (IgY immunized), treated once intranasally...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>Sera of 10 immunized mice per group were collected on days 15, 30, 45, 60, 75 and 90 after the fi...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
<p>Cohorts of BALB/c mice (n = 10/group) received a primary immunization on day 0 followed by three ...
<p>BALB/c mice were immunized with J8-DT/DT or PBS parenterally. For <i>in vivo</i> depletion of CD4...
<p>BALB/c mice were immunized with J8-DT/DT or PBS parenterally. For <i>in vivo</i> depletion of CD8...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
Vaccination with J8-DT, a leading GAS vaccine candidate, results in protective immunity in mice. Ana...
Vaccination with J8-DT, a leading GAS vaccine candidate, results in protective immunity in mice. Ana...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
<p>The development of J8-specific antibodies in mice (n = 5/group) that were sequentially infected w...
<p>Values shown represent the reciprocal of the endpoint ELISA titer for each mouse (closed circles)...
<p>Anti IgY in the sera of mice immunized with normal IgY (IgY immunized), treated once intranasally...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>Sera of 10 immunized mice per group were collected on days 15, 30, 45, 60, 75 and 90 after the fi...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...